ABOUT US

DNAPrint Genomics, Inc. is a cutting edge company. We are concentrating our efforts in four distinct areas; Pharmacogenomics, Forensics, Genotyping, and Consumer Products. Our aim is to continue to research and develop novel products and services in each of these market areas and to be a leader in genomic-based technologies.

The Company’s core patent applied for and proprietary technologies for efficiently targeting single nucleotide polymorphisms (“SNPs”) enable us to provide novel predictive genetic tests at a significant cost advantage over our competitors.

We have identified and applied for patents to cover the maps of certain SNPs that we believe have broad commercial applications. These commercially valuable SNPs are called Ancestry Informative Markers (“AIMs”) and are an integral part of our proprietary Admixture Mapping (“Mapping”) method. With our mapping, we leverage known statistical data about population structure to substantially reduce the number of SNPs analyzed and therefore more cost effectively identify genes responsible for certain traits. Our proprietary data and analytical resources for using AIMs are integral to our strategy of offering DNA tests that provide value in other ways too – from better study design using more traditional methods and generating valuable predictive results, including a person’s physical characteristics, BioGeographical Ancestry (“BGA”), and predisposition to respond to certain pharmaceutical drugs.

WE ARE CURRENTLY FOCUSING OUR EFFORTS IN FOUR DISTINCT MARKETS:

Consumer DNA Products Market - There is an established market of consumers who recreationally research their genealogy and ancestral origin but only recently has it become possible to apply modern advances in genome technology to this endeavor. AncestryByDNA™, the flagship product of our Genealogy line of services and products, now makes it affordable for the general public to use the power of genomics to discover their genetic ancestry. This is a great tool for individuals or groups interested in more deeply and scientifically exploring their genetic heritage and often customers are able to learn something about their lineage that is several thousand years old. By submitting a DNA sample to our lab, customers receive an impressive and detailed analysis of their BioGeographical origins

Forensics DNA Testing Market - Testing DNA to create a physical description from crime scene DNA and providing a photo database array of representatives closely matching the analyzed DNA, allows detectives a means of describing ‘persons of interest’. This presumptive test method is a new market based on evolving DNAPrint® technologies. Common hereditary traits such as skin pigmentation, eye color, hair color, facial geometry and even height can be predicted through analysis of DNA sequences. This can be done indirectly, through an extensive knowledge of ancestry admixture or for certain genetic traits, directly through knowledge of the underlying genes. At DNAPrint® we use both methods. Our goal is to continue to lead the field of forensic presumptive testing using our DNAWitness line of products and services.

Pharmacogenomics Market - The testing of individuals to predict their genetic predisposition to drug response is known as pharmacogenomics. Pharmacogenomics enables physicians to tailor drug therapies (formulation and dosage) for individuals based on their genetic composition, increasing rates of therapeutic success and decreasing rates of adverse side effects. Drug discovery companies are beginning to use pharmacogenomics technologies to develop drugs that are suitable for subpopulations based upon their genetic composition. We at DNAPrint® believe that as doctors and health care providers have been reporting for thousands of years; that different peoples from different countries have variable responses to medications is reason enough for us to explore this realm of medicine. We hope to be able to help predict whether a woman taking a chemotherapy agent for a cancer will respond favorably to a drug. We also will apply our technology to our own therapeutics, such as PT-401 a ‘super EPO’. This will help improve the efficacy of the drug therapy going into clinical evaluation as well as helping to improve and maintain patient response efficacy after the drug is approved. Pharmaceutical and pharmaceutical diagnostics are important cornerstones for our future value to our shareholders. We believe individualized medicine, while still some years away, will be here to stay, especially now that the U.S. FDA has written about pharmacogenomics. view PDF

Contract Service Outsourcing Market -  DNAPrint® provides universities and drug discovery companies with genotyping services. The service provides our clients with the ability to screen efficiently and effectively for genes that may be responsible for certain human traits and/or disease states.